• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HTL-STREFA BD PEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HTL-STREFA BD PEN NEEDLE Back to Search Results
Device Problems Bent (1059); Insufficient Flow or Under Infusion (2182)
Patient Problem Underdose (2542)
Event Date 10/24/2017
Event Type  Injury  
Event Description
New droplet brand of pen needles did not allow for appropriate insulin flow and bent upon administration.Switched to previous brand of bd pen needles, insulin administration returned to normal.Symptoms: unable to get full dose of insulin with new needle; suspect drug, dosing: as directed with insulin.Dates of use: (b)(6) 2017 through na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PEN NEEDLE
Type of Device
NEEDLE
Manufacturer (Section D)
HTL-STREFA
MDR Report Key7285541
MDR Text Key100672841
Report NumberMW5075369
Device Sequence Number0
Product Code FMI
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 02/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2018
Is this an Adverse Event Report? Yes
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age63 YR
-
-